AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 80 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,975,000 | +55.0% | 146,841 | -59.1% | 0.00% | 0.0% |
| Q3 2019 | $1,919,000 | -19.5% | 359,091 | -0.9% | 0.00% | 0.0% |
| Q2 2019 | $2,384,000 | +0.3% | 362,339 | -0.9% | 0.00% | 0.0% |
| Q1 2019 | $2,376,000 | -5.1% | 365,510 | -0.5% | 0.00% | 0.0% |
| Q4 2018 | $2,504,000 | +2.1% | 367,206 | -0.6% | 0.00% | 0.0% |
| Q3 2018 | $2,452,000 | +45.2% | 369,352 | +23.1% | 0.00% | 0.0% |
| Q2 2018 | $1,689,000 | +25.2% | 299,992 | +15.4% | 0.00% | 0.0% |
| Q1 2018 | $1,349,000 | +25.5% | 259,854 | +9.5% | 0.00% | – |
| Q4 2017 | $1,075,000 | -19.0% | 237,353 | +12.2% | 0.00% | -100.0% |
| Q3 2017 | $1,327,000 | +43.0% | 211,569 | +39.7% | 0.00% | – |
| Q2 2017 | $928,000 | – | 151,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |